TY - JOUR T1 - Correction: High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC JF - Journal for ImmunoTherapy of Cancer JO - J Immunother Cancer DO - 10.1136/jitc-2021-004197corr1 VL - 10 IS - 6 SP - e004197corr1 A2 - , Y1 - 2022/06/01 UR - http://jitc.bmj.com/content/10/6/e004197corr1.abstract ER -